DBV Technologies (DBVT) Goodwill & Intangibles (2014 - 2026)
DBV Technologies (DBVT) reported Goodwill & Intangibles of $100000.0 for Q1 2026, up 244.83% year-over-year from $29000.0 in Q1 2025, and up 376.19% on a QoQ basis from $21000.0 in Q3 2025.
DBV Technologies (DBVT) has 13 years of Goodwill & Intangibles data on file, last reported at $100000.0 in Q1 2026.
- Quarterly Goodwill & Intangibles rose 244.83% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100000.0 (up 244.83% YoY) and the FY2024 annual result came in at $40000.0, down 31.03% from the prior year.
- Goodwill & Intangibles climbed to $100000.0 in Q1 2026 per DBVT's latest filing, from $21000.0 in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $100000.0 in Q1 2026 and bottomed at $10000.0 in Q4 2022.
- The 5-year median for Goodwill & Intangibles is $34500.0 (2024), against an average of $37937.5.
- The widest annual swing landed in 2022, when Goodwill & Intangibles tumbled 57.69%; it then jumped 480.0% in 2023.
- Tracing DBVT's Goodwill & Intangibles over 5 years: stood at $10000.0 in 2022, then jumped by 480.0% to $58000.0 in 2023, then slumped by 31.03% to $40000.0 in 2024, then plunged by 47.5% to $21000.0 in 2025, then soared by 376.19% to $100000.0 in 2026.
- Per Business Quant, the three latest DBVT Goodwill & Intangibles figures stand at $100000.0 (Q1 2026), $21000.0 (Q3 2025), and $26000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 68,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Sep 30, 2022 | 11,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Mar 31, 2021 | 32,000.00 |
| Dec 31, 2020 | 41,000.00 |
| Jun 30, 2020 | 46,261.33 |
| Dec 31, 2019 | 47,596.17 |
| Sep 30, 2019 | 53,411.04 |
| Jun 30, 2019 | 25,843.70 |
| Dec 31, 2018 | 33,100.50 |
| Jun 30, 2018 | 31,029.55 |
| Dec 31, 2017 | 144,824.20 |
| Jun 30, 2017 | 171,529.69 |
| Dec 31, 2016 | 103,653.53 |
| Jun 30, 2016 | 257,611.51 |
| Dec 31, 2015 | 103,035.02 |
| Jun 30, 2015 | 53,607.09 |
| Dec 31, 2014 | 36,038.95 |